2BB score and signals
Capricor Therapeutics, Inc.’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 29 | Low |
| Momentum | 52 | Stable |
| Financial strength | 2 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| CEO | Linda Marban |
| Founded | 2005 |
| Employees | 231 |
| 52-week range | $2.96 – $40.37 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.1568 | — | $50.24M |
| 2026-08-12 | — | -0.6018 | — | $0.00 |
| 2026-05-11 | — | -0.4838 | — | $0.00 |
| 2026-03-17 | — | -0.5508 | — | $0.00 |
Related companies
2BBBullish & Bearish